Mohsen Vakili Sadeghi, Zeinab Vosough, Davoud Jahansouz
{"title":"Cold Agglutinin Syndrome as the Initial Presentation of Acute Myeloid Leukemia: A Case Report","authors":"Mohsen Vakili Sadeghi, Zeinab Vosough, Davoud Jahansouz","doi":"10.1002/ccr3.71061","DOIUrl":null,"url":null,"abstract":"<p>Cold agglutinin-mediated autoimmune hemolytic anemia, when secondary to viral and bacterial infections or, rarely, malignancy, is called cold agglutinin syndrome. This is the first case in which acute myeloid leukemia (AML) was the underlying cause of this syndrome. Here, we present a 64-year-old man with weight loss, jaundice, anemia, and a recent episode of red urine. The blood drawn from the patient clotted swiftly, and then the cold agglutinin test became positive. Bone marrow specimen microscopy revealed monocytic AML. Standard treatment resulted in clinical improvement, although he later faced progression to hyperleukocytosis and liver failure, which led to his death. This case emphasizes the necessity of maintaining a level of suspicion for underlying hematologic malignancies in individuals with secondary cold agglutinin-mediated hemolytic anemia. This is the first documented case of cold agglutinin syndrome related to AML, contributing to the growing knowledge of the connection between autoimmune hemolytic anemia and hematologic cancers.</p>","PeriodicalId":10327,"journal":{"name":"Clinical Case Reports","volume":"13 10","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480438/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ccr3.71061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Cold agglutinin-mediated autoimmune hemolytic anemia, when secondary to viral and bacterial infections or, rarely, malignancy, is called cold agglutinin syndrome. This is the first case in which acute myeloid leukemia (AML) was the underlying cause of this syndrome. Here, we present a 64-year-old man with weight loss, jaundice, anemia, and a recent episode of red urine. The blood drawn from the patient clotted swiftly, and then the cold agglutinin test became positive. Bone marrow specimen microscopy revealed monocytic AML. Standard treatment resulted in clinical improvement, although he later faced progression to hyperleukocytosis and liver failure, which led to his death. This case emphasizes the necessity of maintaining a level of suspicion for underlying hematologic malignancies in individuals with secondary cold agglutinin-mediated hemolytic anemia. This is the first documented case of cold agglutinin syndrome related to AML, contributing to the growing knowledge of the connection between autoimmune hemolytic anemia and hematologic cancers.
期刊介绍:
Clinical Case Reports is different from other case report journals. Our aim is to directly improve global health and increase clinical understanding using case reports to convey important best practice information. We welcome case reports from all areas of Medicine, Nursing, Dentistry, and Veterinary Science and may include: -Any clinical case or procedure which illustrates an important best practice teaching message -Any clinical case or procedure which illustrates the appropriate use of an important clinical guideline or systematic review. As well as: -The management of novel or very uncommon diseases -A common disease presenting in an uncommon way -An uncommon disease masquerading as something more common -Cases which expand understanding of disease pathogenesis -Cases where the teaching point is based on an error -Cases which allow us to re-think established medical lore -Unreported adverse effects of interventions (drug, procedural, or other).